Insiders · KLTO

KLTO insider transactions

Klotho Neurosciences Inc. (KLTO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for KLTO

• 51d
  Chief Financial Officer Leblanc Jeff was granted 2,500,000 shares, increasing direct ownership by 272% to 3,420,342 units (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 51d
  Director El-Dada Riad Hussein was granted 350,000 shares (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 51d
  Director Zentman Samuel M was granted 350,000 shares, increasing direct ownership by 48% to 1,086,440 units (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 51d
  Director Hirschman Shalom was granted 350,000 shares, increasing direct ownership by 63% to 908,873 units (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 51d
  Director Mcgarity Jon was granted 350,000 shares, increasing direct ownership by 571% to 411,277 units (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 51d
  Chief Executive Officer Sinkule Joseph was granted 2,500,000 shares, increasing direct ownership by 65% to 6,346,700 units (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 137d
  SEC Form 4 filed by Director Mcgarity Jon

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 137d
  SEC Form 4 filed by Director Zentman Samuel M

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 137d
  SEC Form 4 filed by Director El-Dada Riad Hussein

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 209d
  Chief Executive Officer Sinkule Joseph acquired 400,000 shares, increasing direct ownership by 9% to 4,846,700 units (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 243d
  Chief Financial Officer Leblanc Jeff was granted 200,000 shares, increasing direct ownership by 28% to 920,342 units (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 261d
  Chief Executive Officer Sinkule Joseph disposed of 2,000,000 shares and was granted 537,180 shares, decreasing direct ownership by 25% to 4,446,700 units (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 261d
  Director Zentman Samuel M was granted 153,494 shares (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 261d
  Director Hirschman Shalom was granted 70,149 shares, increasing direct ownership by 14% to 558,873 units (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 261d
  Chief Financial Officer Leblanc Jeff was granted 156,199 shares, increasing direct ownership by 28% to 720,342 units (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 261d
  SEC Form 4 filed by Director El-Dada Riad Hussein

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)
• 261d
  Director Mcgarity Jon was granted 14,641 shares (SEC Form 4)

  4 - Klotho Neurosciences, Inc. (0001907223) (Issuer)